- Home
- CDIO vs PETZ Comparison
CDIO vs PETZ Comparison
Compare CDIO & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- PETZ
- Stock Information
- Founded
- CDIO 2017
- PETZ 2002
- Country
- CDIO United States
- PETZ China
- Employees
- CDIO N/A
- PETZ N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- PETZ Steel/Iron Ore
- Sector
- CDIO Health Care
- PETZ Industrials
- Exchange
- CDIO Nasdaq
- PETZ Nasdaq
- Market Cap
- CDIO 7.9M
- PETZ 9.3M
- IPO Year
- CDIO N/A
- PETZ 2017
- Fundamental
- Price
- CDIO $3.61
- PETZ $0.98
- Analyst Decision
- CDIO Buy
- PETZ
- Analyst Count
- CDIO 1
- PETZ 0
- Target Price
- CDIO $60.00
- PETZ N/A
- AVG Volume (30 Days)
- CDIO 56.5K
- PETZ 11.4K
- Earning Date
- CDIO 08-11-2025
- PETZ 04-28-2025
- Dividend Yield
- CDIO N/A
- PETZ N/A
- EPS Growth
- CDIO N/A
- PETZ N/A
- EPS
- CDIO N/A
- PETZ 0.26
- Revenue
- CDIO $19,902.00
- PETZ $563,726.00
- Revenue This Year
- CDIO $1,434.82
- PETZ N/A
- Revenue Next Year
- CDIO $4,661.91
- PETZ N/A
- P/E Ratio
- CDIO N/A
- PETZ $4.77
- Revenue Growth
- CDIO N/A
- PETZ 74664.72
- 52 Week Low
- CDIO $3.22
- PETZ $0.65
- 52 Week High
- CDIO $53.10
- PETZ $1.74
- Technical
- Relative Strength Index (RSI)
- CDIO 32.36
- PETZ 44.43
- Support Level
- CDIO $3.65
- PETZ $0.90
- Resistance Level
- CDIO $4.18
- PETZ $1.05
- Average True Range (ATR)
- CDIO 0.31
- PETZ 0.07
- MACD
- CDIO 0.12
- PETZ -0.01
- Stochastic Oscillator
- CDIO 4.49
- PETZ 31.62
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.